nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—CCKBR—forebrain—attention deficit hyperactivity disorder	0.0954	0.271	CbGeAlD
Pentagastrin—CCKBR—nervous system—attention deficit hyperactivity disorder	0.0518	0.147	CbGeAlD
Pentagastrin—CCKBR—central nervous system—attention deficit hyperactivity disorder	0.0499	0.142	CbGeAlD
Pentagastrin—CCKBR—cerebellum—attention deficit hyperactivity disorder	0.0488	0.138	CbGeAlD
Pentagastrin—CCKBR—brain—attention deficit hyperactivity disorder	0.0396	0.112	CbGeAlD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.031	0.0479	CbGpPWpGaD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0264	0.0408	CbGpPWpGaD
Pentagastrin—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0262	0.0405	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0229	0.0353	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0222	0.0343	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0186	0.0287	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0182	0.0281	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0181	0.0279	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0159	0.0246	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0156	0.0241	CbGpPWpGaD
Pentagastrin—BCHE—forebrain—attention deficit hyperactivity disorder	0.0149	0.0422	CbGeAlD
Pentagastrin—CCKBR—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.0145	0.0224	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0126	0.0195	CbGpPWpGaD
Pentagastrin—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.0126	0.0356	CbGeAlD
Pentagastrin—CCKBR—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0121	0.0187	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0119	0.0184	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.011	0.017	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0108	0.0167	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0103	0.0158	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0102	0.0158	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00994	0.0153	CbGpPWpGaD
Pentagastrin—BCHE—midbrain—attention deficit hyperactivity disorder	0.00981	0.0278	CbGeAlD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00977	0.0151	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00965	0.0149	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00946	0.0146	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00928	0.0143	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00899	0.0139	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00879	0.0136	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00851	0.0131	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00837	0.0129	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00827	0.0128	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00824	0.0127	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00814	0.0126	CbGpPWpGaD
Pentagastrin—BCHE—nervous system—attention deficit hyperactivity disorder	0.00806	0.0229	CbGeAlD
Pentagastrin—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00776	0.022	CbGeAlD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0077	0.0119	CbGpPWpGaD
Pentagastrin—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00759	0.0215	CbGeAlD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00728	0.0112	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0072	0.0111	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00686	0.0106	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00672	0.0104	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00669	0.0103	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00648	0.01	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00648	0.01	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00637	0.00984	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00629	0.00972	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00629	0.00972	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00623	0.00961	CbGpPWpGaD
Pentagastrin—BCHE—brain—attention deficit hyperactivity disorder	0.00616	0.0175	CbGeAlD
Pentagastrin—CCKBR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0061	0.00942	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00586	0.00905	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00548	0.00847	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00539	0.00833	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00497	0.00767	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00466	0.00719	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00428	0.00661	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00423	0.00653	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00411	0.00634	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00407	0.00628	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00378	0.00584	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0037	0.00571	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00368	0.00568	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00366	0.00566	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0036	0.00556	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0036	0.00556	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00356	0.00549	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00353	0.00546	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00344	0.0053	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00333	0.00514	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00332	0.00512	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00331	0.00512	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00327	0.00505	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00323	0.00499	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00301	0.00465	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00285	0.0044	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00265	0.00409	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00254	0.00392	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0025	0.00386	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00236	0.00365	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00232	0.00358	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00219	0.00337	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00218	0.00337	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00211	0.00325	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00203	0.00314	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00203	0.00313	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00201	0.0031	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.002	0.00308	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00197	0.00303	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00193	0.00298	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00191	0.00295	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00181	0.0028	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00178	0.00274	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00154	0.00238	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00153	0.00236	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00125	0.00192	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000927	0.00143	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00066	0.00102	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00064	0.000988	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00064	0.000988	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00063	0.000972	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000585	0.000904	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000512	0.00079	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000487	0.000752	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000388	0.000599	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000385	0.000595	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000373	0.000577	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000166	0.000257	CbGpPWpGaD
